On May 14, life sciences partner Katherine Wang (Shanghai) chaired a medical device regulatory affairs roundtable co-organized with McKinsey & Company and held in Beijing. The roundtable brought together senior regulatory affairs leaders from multinational medical device companies to discuss recent China Food and Drug Administration regulatory changes and best practices for tackling the challenges ahead. Katherine led lively discussions addressing the key regulatory reforms affecting multinational medical device companies, aligning the Chinese regulatory requirements with global development, and building industry channels to influence and shape future policies.
The event was very well received, and featured about 10 participants from Medtronic, Baxter, Siemens, St. Jude Medical, 3M, Fresenius, and Abbott.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.